Osteopore (ASX:OSX) has announced that US-based distributor Bioplate has secured a non-exclusive agreement with MellingMedical to promote and sell its products within healthcare facilities owned or operated by the US government.
Latest News
New Stories
-
Osteopore secures US distribution agreement for government facilities
August 4, 2022 - - Latest News -
Radiopharm Theranostics announces new agreements with Lantheus and NanoMab
August 4, 2022 - - Latest News -
Medical Developments International announces fully underwritten capital raise
August 4, 2022 - - Latest News -
Pfizer raises offer for Australian digital health company
August 4, 2022 - - Latest News -
AusBiotech 2022 programme features top industry experts
August 4, 2022 - - AusBiotech -
Australia’s Cell and Gene Catalyst moves ahead
August 2, 2022 - - AusBiotech -
New study published demonstrating the utility of PromarkerD test
August 2, 2022 - - Latest News